Zolbetuximab MMAE (IMAB362 MMAE) is a compound targeting Claudin 18.2 (CLDN18.2) with anti-cancer activity, used in the study of gastric and pancreatic cancers.
Purity:
99.40%
Target:
Tight Junction Protein|||Others
* VAT and and shipping costs not included. Errors and price changes excepted